Fischer Laurent
SEC-identified person · CIK 1379344 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Mirum Pharmaceuticals, Inc. MIRM | Director | filed 2019 - 2026 |
| Ataibeckley Inc. ATAI | Director | filed 2026 - 2026 |
| Avalanche Biotechnologies, Inc. [AAVL] | Director · CEO, President and Director | filed 2020 - 2025 |
| Atai Beckley N.V. ATAI | Director | filed 2024 - 2025 |
| CTI Biopharma Corp ctic | Director | filed 2017 - 2023 |
| Tobira Therapeutics, Inc. TBRA | Director · Chief Executive Officer | filed 2015 - 2016 |
| Panacos Pharmaceuticals, INC. PANC | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.